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Abstract  
AIM: The purpose of the actual study was to evaluate the relationship between the formation of 
anti-inflammatory cytokine IL10 and several indicators of moderate and severe preeclampsia in the 
third trimester of pregnancy. 
MATERIAL AND METHODS: Examination of the indicators of preeclampsia and maternal IL10 
levels was conducted in 50 women with pregnancies complicated by varying degrees of 
preeclampsia in the third trimester of gestation as well as in 50 normotensive patients, hospitalized 
at the University Clinic of Gynecology and Obstetrics, Skopje, Republic of Macedonia. The levels of 
IL10 were determined with a commercial test developed by Orgenium Laboratories (Finland), using 
reagents from AviBion ELISA research kits. Patients with preeclampsia were categorized into 
moderate and severe preeclampsia group according to the degree of preeclampsia. Logistic 
regression analysis was used to determine the predictive value of different parameters for the 
occurrence of severe preeclampsia. Odds ratios and 95% Confidence Intervals were calculated in 
order to quantify independent associations. 
RESULTS: The regression analysis detected systolic blood pressure (160 mmHg or higher), 
diastolic blood pressure (100 mmHg or higher), persistent proteinuria in pregnancy, serum LDH 
concentration (450 U/L or higher) and reduced serum concentrations of IL10 as significant 
predictors of severe preeclampsia in pregnant women after adjusting for age.  
CONCLUSION: The findings of significantly lower serum IL10 concentrations in patients with 
severe preeclampsia in comparison with respective concentrations in patients with moderate 
preeclampsia can be considered as major pathognomonic laboratory sign of severe preeclampsia. 
 
 
 
Introduction 
 
Accommodation of the fetoplacental unit in 
human pregnancy requires maternal immune 
tolerance to this “semiallograft”. The acceptance of 
the fetoplacental unit by the maternal uterine surface 
requires an element of immunological tolerance. 
Despite close examination of the features of 
the process, preeclampsia remains one of the most 
sophisticated problems of modern obstetrics and 
gynecology. It generally determines maternal and 
perinatal morbidity and mortality [1, 2]. The role of 
immune mechanisms contributing to the development 
of normal pregnancy is widely discussed. Their 
involvement in the pathogenesis of pregnancy 
complications, such as preeclampsia, was also noted 
[3]. The analysis of scientific literature reveals 
conclusion that many aspects of the pathogenesis of 
preeclampsia are related to a syndrome of systemic 
inflammatory response characterized by development 
of a destructive inflammatory process, immune 
disorders, and imbalanced cytokine regulation of 
gestation processes [4-6].  
The role of vascular endothelial damage with 
development of generalized arteriolar spasm is 
described as one of the leading mechanisms in the 
pathogenesis of preeclampsia. However, the 
relationship between development of endothelial 
dysfunction and disruption of cytokine regulation in 
different clinical forms of preeclampsia, currently 
published in several studies, also requires further 
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research [7].  
Proteinuria has been studied as both an 
indicator of the severity of the disease and predictor of 
the outcome in preeclampsia. Many clinicians still 
base their major management decisions on the 
degree of proteinuria in these patients. 
In 1843, John Lever from the Guy's Hospital 
in London discovered the presence of albumin by 
boiling the urine in pregnant women with puerperal 
convulsions. Preeclampsia is differentiated from 
gestational hypertension by the presence of 
proteinuria and it is the most common cause of 
nephrotic syndrome in pregnancy. The quantity of 
protein that is excreted in the urine varies widely. 
Significant protein excretion is defined as ≥300 mg 
protein in a 24-h urine collection or mark of 1+ or 
greater on urine dipstick testing of two random urine 
samples that are collected at least 4 h apart [8]. 
The serum uric acid level was used as an 
indicator of preeclampsia but it has been found that it 
lacks sensitivity and specificity as a diagnostic 
tool. However, an elevated serum uric acid level may 
be used in the identification of pregnant women with 
chronic hypertension who have an increased 
likelihood to develop superimposed preeclampsia [9].  
A lactate dehydrogenase (LD or LDH) test is a 
non-specific test that may be used in the evaluation of 
different diseases and conditions. Thus, the blood 
level of LD is a general indicator of tissue and cellular 
damage and it is used as one of the indicators of 
preeclampsia [10]. Several studies have confirmed the 
accentuation of platelet activation in preeclampsia 
which remains an important obstetric complication 
affecting 2 to 4% of all pregnancies. Detection of 
aberrations of platelet function and activation appear 
to have predictive value for the diagnosis [11]. 
 Studies showed that in pregnancy 
complicated by preeclampsia, cytokine levels 
essentialy change compared to the respective levels 
in physiological pregnancy. Thus, even a moderate 
form of preeclampsia shows directional change, i.e., 
elevated levels of pro- and anti-inflammatory 
cytokines, with the exception of IL-10, while a 
downward trend is recorded in severe preeclampsia. 
  The purpose of the actual study was to 
evaluate the relationship between formation of anti-
inflammatory IL10 cytokine and several indicators of 
moderate and severe preeclampsia in the third 
trimester of pregnancy. 
 
 
Material and Methods 
 
Examination of the indicators of preeclampsia 
and maternal IL10 levels was conducted in 50 women 
with pregnancies complicated by different degrees of 
preeclampsia in the third trimester of gestation as well 
as in 50 normotensive patients, all hospitalized at the 
University Clinic of Gynecology and Obstetrics, 
Skopje, Republic of Macedonia. Patients with 
preeclampsia were categorized into moderate (m PE) 
and severe (s PE) preeclampsia group according to 
the degree of preeclampsia. The severity of 
preeclampsia was determined according to the 
definition of World Health Organization, Handbook for 
guideline development from 2010.  
 Preeclampsia was defined by an increased 
blood pressure (≥ 140 mmHg systolic or ≥ 90 mmHg 
diastolic blood pressure on ≥ 2 occasions at least 6 
hours apart) that occurred after the 20th week of 
gestation in a woman with previously normal blood 
pressure, accompanied by proteinuria (≥ 0.3 g/24h in 
the absence of urinary tract infection). Preeclampsia 
was defined as severe if any of the following criteria 
was detected: ≥ 160 mmHg systolic or ≥ 110 mmHg 
diastolic blood pressures or proteinuria ≥ 5.0 g/24h.  
 Exclusion criteria for each analyzed group 
included the presence of eclampsia and endocrine 
diseases, such as diabetes mellitus, hyper- or 
hypothyroidism, as well as other endocrine disorders 
requiring hormonal treatment. Additionally, exclusion 
criteria also encompassed the presence of TORCH 
(Toxoplasma, Rubella, Cytomegalovirus, Herpes 
simplex) infections markers and other chronic viral or 
bacterial processes in the acute phase, as well as 
autoimmune diseases and malignant neoplastic 
processes.  
 Patients with preeclampsia were categorized 
into moderate (group A) and severe (group B) 
preeclampsia group according to the degree of 
preeclampsia. Control group (group C) consisted of 50 
women in the third trimester of normotensive 
pregnancy. 
 The levels of IL10 were determined with a 
commercial test developed by Orgenium Laboratories 
(Finland), using reagents from AviBion ELISA 
research kits. Cytokine levels in the serum were 
measured by a "sandwich" method of solid-phase 
enzyme immunoassay using double antibody. 
Recombinant cytokines that are part of the test whale 
were used as a standard for comparison of each 
reaction. The detection was performed by "Victor" 
immunoassay analytics. According to the titration of 
standard samples, calibration graphs were made for 
each cytokine, determined by their level in the range 
of detected concentrations (1-2000 pg/ml). 
 Statistical data analysis was performed using 
the SPSS statistical package for Windows, version 
13.0. Logistic regression analysis (Binary Logistic 
Regression) was used to determine the predictive 
value of different parameters for the occurrence of 
severe preeclampsia. Rates of probability - odds 
ratios (OR) and 95% Confidence Intervals (CI) were 
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calculated in order to quantify independent 
associations.  
 
 
Results  
 
 Table 1 shows significant difference in 
average age between pregnant women with moderate 
(mPE) and severe (sPE) preeclampsia (mPE 29.9 ± 
4.7 years vs. sPE 34.2 ± 3.85 years, p = 0.004). 
Pregnant women of the analyzed groups did not differ 
significantly in terms of average length of gestational 
age, which ranges from 34.4 ± 3.6 weeks in the group 
with severe PE to 35.5 ± 3.4 weeks in the group with 
symptoms of moderate PE.  
 
Table 1: Age, gestational week, BMI and IL10 serum 
concentration in women with moderate and severe 
preeclampsia, and women with normal blood pressure (control 
group)  
Variable 
Groups 
All PE 
N = 50 
moderate PE 
(mPE) 
N = 25 
severe PE 
(sPE) 
N = 25 
Control 
(C) 
N = 50 
Age (years) 
mean ± SD 
32.06 ± 4.8 29.9 ± 4.7 34.2 ± 3.85 31.8 ± 4.8 
All PE/C; t = 0.27; p = 0.8       
mPE/sPE/C; F = 5.5; p = 0.005; post hoc  mPE/sPE p = 0.004 
Gestational 
week mean 
± SD 
34.99 ± 3 .5 35.5 ± 3.4 34.4 ± 3.6 34.8 ± 3.6 
All PE/C; t = 0.2; p = 0.8         
mPE/sPE/C; F = 0.6; p = 0.5 
Ethnicity n (%) 
Macedonian 18 (36%) 10 (40%) 8 (32%) 15 (30%) 
Albanian 28 (56%) 11 (44%) 17 (68%) 34 (68%) 
Romani  4 (8%) 4 (16%) 0 1 (2%) 
BMI mean ± 
SD, rang 
34.33 ± 4.5 
24.2 - 44 
33.1 ± 4.7 
24.2 - 41 
35.57 ± 4.1 
27 - 44 
32.88 ± 3.8 
27 - 43.9 
All PE/C; t =1.7; p = 0.09                
mPE/sPE/C; F = 3.8; p = 0.026; post hoc  sPE/C p = 0.025 
IL-10 
mean 
±SD, 
median, 
rang 
23.2 ± 40.7 
1.36 
0.2 - 164 
45.5 ± 48.4 
27.28 
0.56 - 164 
0.8 ± 0.4 
0.75 
0.2 - 2.12 
4.2 ± 6.7 
1.47 
0.44 - 26.28 
All PE/C; Z = 0.6; p = 0.5 
M PE/sPE/C; H = 37.68; p < 0.01 
Platelets 
(x10
9
/L) 
mean±SD, 
rang 
242.8 ± 68.2 
100 - 401 
268.9 ± 60.4 
189 - 401 
216.6 ± 67.4 
100 - 320 
285.2 ± 62.5 
179 - 450 
mPE/C ; t = 3.2; p < 0.01 
mPE/sPE/C; F = 9.9; p < 0.01 
 
  Regarding ethnicity, Albanians represented 
more than a half in group with preeclampsia (44% of 
participants with moderate and 68% of participants 
with severe PE). 
 The average BMI in the group of pregnant 
women with preeclampsia was 34.33 ± 4.5 that was 
not significantly higher than the average BMI of the 
control group (32.8 8 ± 3.8) (p = 0.09). However, the 
difference between the average BMI of pregnant 
women with moderate and severe PE, and 
normotensive pregnant patients was significant (F = 
3.8, p = 0.026). Namely, pregnant women with severe 
PE had significantly higher average BMI than 
normotensive pregnant women (35.57 ± 4.1 vs. 32.88 
± 3.8; p = 0.025). 
 Statistical analysis showed not significant 
differences in serum levels of IL10 between pregnant 
women with preeclampsia and healthy pregnant 
women (p = 0.5). The difference of IL10 serum levels 
between moderate preeclampsia, severe 
preeclampsia, and control group was highly significant 
(p < 0.01) due to:  
- Lower levels of this interleukin in severe 
preeclampsia group,  
- Differences between moderate preeclampsia 
and control group, and  
- Significantly lower values when comparing 
control group in relation to moderate preeclampsia 
group.  
Average serum concentrations of IL10 were 
23.2 ± 40.7 pg/ml in the total group of preeclampsia 
patients, 45.5 ± 48.4 pg/ml in the group with moderate 
preeclampsia, and 0.8 ± 0.4 pg/ml in the group with 
severe preeclampsia. In patients with normal tension, 
the average serum concentration of IL10 was 4.2 ± 
6.7 pg/ml.  
Study data demonstrated that in pregnant 
women with pregnancy complicated by preeclampsia, 
the serum concentration of anti-inflammatory IL10 is 
confirmed as a significant predictor of the occurrence 
of severe preeclampsia. Increased serum 
concentrations of IL10 (in pg/mL) reduced the 
likelihood of the development of severe preeclampsia 
by 89.6% (95% CI 0.016-0.678). 
Table 2 shows predictors of severe 
preeclampsia using multivariate logistic regression 
analysis.  
Table 2: Multivariate logistic regression analysis for the factors 
predictors of severe preeclampsia 
Variable B S.E. Wald p Exp (B) 
95% CI for 
Exp (B) 
Age  
(years) 
0.2 0.086 5.350 0.021 1.221 1.031 1.446 
Nulparity  
(present) 
1.816 1.114 2.657 0.103 6.145 0.692 54.534 
Systolic blood 
pressure 
(≥ 160 mmHg) 
3.711 1.053 12.412 <0.001 40.9 5.189 322.371 
Diastolic blood 
pressure 
(≥ 100 mmHg) 
2.414 0.843 8.192 0.004 11.176 2.140 58.360 
Proteinuria  
(present) 
3.081 1.307 5.56 0.018 21.785 1.682 282.123 
LDH ≥ 450 
(U/L) 
2.066 0.915 5.102 0.024 7.896 1.314 47.433 
Albumin (serum) 
(g/L) 
-0.239 0.125 3.66 0.056 0.787 0.616 1.006 
Creatinine (serum) 
(umol/L) 
-0.067 0.035 3.696 0.055 0.935 0.873 1.001 
Platelets  
(≤ 150 000) 
-0.006 0.013 0.236 0.627 0.994 0.97 1.019 
IL10 
(pg/ml) 
-2.324 1.051 4.888 0.027 0.098 0.012 0.768 
Dependent variable: severe preeclampsia 
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Table 2 presents the results of multivariate 
logistic regression analysis for determining the 
independent associations between the analyzed 
variables and severe preeclampsia. The variables or 
risk factors that showed significant predictive value 
within univariate analysis were included in the 
multivariate regression analysis. The age of the 
participant was used as a control variable.  
Correlation: r = -,2146
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Figure 1: Correlation IL10 / LDH. r = - 0.215; p = 0.134 
 
The regression analysis detected systolic 
blood pressure (160 mmHg or higher), diastolic blood 
pressure (100 mmHg or higher), persistent proteinuria 
in pregnancy, the serum LDH concentration (450 U/L 
or higher) and reduced serum concentrations of IL10 
as independent significant predictors of severe 
preeclampsia in pregnant women after adjusting for 
age. The age of the participant was also shown as a 
significant predictor of the occurrence of severe 
preeclampsia. 
Correlation: r = ,13363
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Figure 2: Correlation IL10 / creatinine. r =  0.134; p = 0.355 
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Figure 3: Correlation IL10 / platelets. r =  0.362; p = 0.01 
 
Figures 1, 2, 3, 4, and 5 show the results of 
bivariate analysis of the relationships between serum 
maternal concentration of IL10 and serum enzyme 
LDH, creatinine, platelets, proteinuria, and uric acid, 
respectively.  
Correlation: r = -,4846
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Figure 4: Correlation IL10 / proteinuria. r = - 0.485; p < 0.001 
 
The obtained values of Pearson’s coefficients 
indicate negative correlations of IL10 with LDH and 
proteinuria, whereas the correlations of IL10 with 
creatinine, platelets, and uric acid were positive. 
However, significant correlations were confirmed only 
between IL10 and platelets as well as between IL10 
and proteinuria. The correlation with the platelets 
count was positive which means that significantly 
higher concentration of IL10 was confirmed in patients 
with higher number of platelets in the blood, and vice 
versa. The correlation between IL10 and proteinuria 
was negative showing that the serum concentration of 
IL10 was significantly lower in patients with higher 
amount of proteins in the urine, and vice versa. 
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Correlation: r = ,08566
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Figure 5: Correlation IL10 / uric acid. r = 0.086; p = 0.554 
 
Table 3 shows linear multiple regression 
models testing the predictive value of platelets and 
proteinuria for the serum concentration of IL10 in 
women with preeclampsia. These two parameters 
were confirmed in univariate analysis as variables that 
significantly correlate with IL10 serum concentration.  
The results presented in Table 3 show that 
31.4% of the changes of IL10 can be explained by 
changes in platelet count and persistent proteinuria. 
The platelets and proteinuria were confirmed as 
significant predictors that affect the serum 
concentration of IL10.  
With each increase in the platelets count by 
one 10
9
 per L, the serum concentration of IL10 
increases by 0.169 (95% CI for B 0.023-0.216), while 
any increase in urine proteins by 1 g/L, the serum 
concentration of IL10 is reduced by approximately 
10.099 (95% CI for B -15.848; -4.351).  
Table 3: Significant independent predictors of IL10 serum 
concentration 
Adjusted R Square = 0.314        R = 0.56                                 F = 10.74  df = 2  p<0,001 
 Unstandardized 
Coefficients 
Standardized 
Coefficients  
 
t 
 
 
p 
95% CI for B 
B S.E. Beta 
Lower 
Bound 
Upper 
Bound 
Constant 11.754 21.430  0.548 0.586 -31.358 54.865 
Platelets 0.169 0.073 0.285 2.325 0.024 0.023 0.316 
Proteinuria -10.099 2.857 -0.434 -3.534 0.001 -15.848 -4.351 
Dependant variable: IL10 serum concentration 
 
Beta coefficients show that greater impact on 
the serum concentration of IL10 has a degree of 
proteinuria (Beta = - 0.434). 
 Figure 6 shows that mean platelets count is 
significantly lower in severe preclampsia group than in 
moderate preeclampsia group. 
 
Figure 6:  Platelets count in moderate and severe preeclampsia. 
Yates Chi-square = 4.73; df = 1; p = 0.029 
 
 
Discussion 
 
 This study demonstrates differences in IL10 
levels in women with preeclampsia compared to the 
levels in women with a normal pregnancy outcome. 
 We found that in pregnant women with 
preeclampsia, the increased serum concentrations of 
IL10 predicted lower likelihood for the development of 
severe preeclampsia. IL10 has been identified as an 
important cytokine in pregnancy. It may be involved in 
the maintenance of pregnancy by corpus luteum 
maturation and progesterone production [12]. Ovarian 
corpus luteum cell growth was stimulated by 
exogenous IL10 and also in the presence of Th2 type 
lymphocytes derived during early pregnancy. In a 
well-known mouse cross that is prone to spontaneous 
abortion, a deficiency of IL10 has been demonstrated 
to alter the net fetal number and outcome [13]. 
Longitudinal studies in mice demonstrate a sequential 
change in the cytokine profile including IL10 in 
peripheral blood and release from spleen elements as 
pregnancy advances [14, 15]. IL10 inhibition in the 
second half of pregnancy in mice causes fetal growth 
retardation [16]. Progesterone has been shown to 
increase Th2-type responses in T cells [17]. Taken 
together, these data suggest that early pregnancy is 
associated with an increase in circulating Th2 cytokine 
IL10. 
 This study demonstrated that there is 
significant alteration in the serum IL10 concentration 
in severe preeclampsia compared to normal 
pregnancy and in moderate preeclampsia group of 
patients. 
 The regression analysis applied in this study 
showed systolic blood pressure of 160 mmHg or 
higher, diastolic blood pressure of 100 mmHg or 
higher, persistent proteinuria in pregnancy, the serum 
LDH concentration of 450 U/L or higher and reduced 
serum concentrations of IL10 as significant predictors 
of severe preeclampsia in pregnant women. While 
other variables predicted higher likelihood for the 
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development of severe preeclampsia, IL10 decreased 
such likelihood. IL10 was also found to be negatively 
correlated with proteinuria, and positively correlated 
with blood platelets. Significantly higher concentration 
of IL10 was confirmed in patients with higher number 
of platelets in the blood, and vice versa. On the other 
hand, serum concentration of IL10 was significantly 
lower in patients with higher amount of proteins in the 
urine, and vice versa. 
 The actual study demonstrated platelets count 
and proteinuria as significant predictors of serum IL10 
concentration - platelets count predicting higher serum 
concentration of IL10, while urine proteins predicting 
lower serum IL10. 
 Some studies suggest a proportional link 
between the level of proteinuria and adverse clinical 
outcomes. Page et al., in a prospective study of 
almost 13,000 pregnant women found that significant 
proteinuria, defined as 2+ or more on dipstick 
analysis, was associated with an increase in stillbirth 
rates, fetal growth restriction and neonatal morbidity, 
when associated with hypertension [18]. Other studies 
suggest that it is the presence of proteinuria rather 
than the severity, which is associated with poorer 
outcomes. There is evidence that even the finding of 
trace proteinuria in pregnant women with hypertension 
is associated with an increase in adverse outcome 
[19]. 
 This may have contributed to the variation in 
the diagnostic performance among the studies [20]. 
Significant proteinuria of 150-180 mg/24h urine has 
been established in the preeclamptic group of this 
study which is similar to finding of Nisell et al. (1995), 
Lindheir et al. (1986) and Davison (1986) who 
reported 300 mg/24h of protein in urine of 
preeclamptic women, while Waugh et al. (2003) 
between 150-200 mg/24h and Higby et al. (1995) who 
recorded between 120-200 mg/24h.  
The mean platelets count was significantly 
lower in severe preclampsia group than in moderate 
preeclampsia group. This study showed decrease of 
platelets counts among the preeclamptic group and 
this is consistent with the findings of other studies [21, 
22], demonstrating that platelet count was significantly 
lower in severe preeclampsia groups. This results 
proposes a possible relationship between the platelet 
count and the severity of preeclampsia. In our 
study the correlation of IL10 with the platelets count 
was positive. 
 Taking into consideration changes of anti-
inflammatory cytokine concentrations in severe 
preeclampsia, moderate phase can be analyzed as a 
critical stage in complicated pregnancies. 
 It can be assumed that moderately aggressive 
factors have a role as initiators of synthesis of 
mediators of intercellular interaction (in moderate 
preeclampsia) and the development of immune 
response is regulated by the interaction of cytokines 
and their antagonists. With increasing severity of the 
pathological process, the impact of regulatory factors 
that limit the systemic effect is reduced.  
 In conclusion, there are dynamic changes in 
maternal concentrations of cytokines in normotensive 
and preeclampsia pregnancy. The findings of 
significantly lower serum IL10 concentrations in 
patients with severe preeclampsia in comparison with 
respective concentrations in patients with moderate 
preeclampsia are highly important. These results can 
be considered as a major pathognomonic laboratory 
sign of severe preeclampsia that can be used by 
clinicians to make difference between severe 
preeclampsia and normal pregnancy, as well as 
between severe and moderate degree of this specific 
pathology. The decrease in serum IL10 
concentrations indicates a depletion of adaptive 
mechanisms aimed at relief of excessive activity of the 
inflammatory process and development of physilogical 
immunosuppression during pregnancy and, 
apparently, can be an additional diagnostic criterion 
for the prediction and assessment of the severity of 
the pathological process. 
These indicators may help in recognizing 
patients with the highest risk of severe preeclampsia. 
Precisely defined time for the termination of 
preeclampsia pregnancy will decrease morbidity and 
mortality from this most difficult disease in pregnancy. 
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